Filing Flows

Filing Flows › Lenz Therapeutics (LENZ) › How it makes money

How Lenz Therapeutics (LENZ) makes money

Lenz Therapeutics (LENZ) made $3.4M of revenue in the third quarter 2026 (Q3 2026), -73% from a year earlier. Product sales, net brought in $2.6M (77%); License revenue brought in $785K (23%).

Drawing the Sankey…

Lenz Therapeutics revenue by segment, Q3 2026Lenz Therapeutics revenue by segment, Q3 2026Product sales, net$2.6MLicense revenue$785K
Lenz Therapeutics: revenue by line, Q1 2026 to Q3 2026Lenz Therapeutics: revenue by line, Q1 2026 to Q3 2026Product sales, netLicense revenueProduct sales, net: $2.6M latest$2.6MLicense revenue: $785K latest$785KQ1 2026Q2 2026Q3 2026
Product sales, net went from 87% of revenue in Q1 2026 to 77% in Q3 2026, the largest shift in the mix.
Lenz Therapeutics revenue by quarterLenz Therapeutics revenue by quarter$5.0MQ2 2025$12.5MQ3 2025$1.9MQ1 2026$5.5MQ2 2026$3.4MQ3 2026

Revenue by segment, Q3 2026

SegmentRevenueShareQ/QY/Y
Product sales, net$2.6M76.8%+50%—
License revenue$785K23.2%-79%-94%

Where each dollar of revenue goes

LineQ3 2026% of revenue
Revenue$3.4M100.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q3 2026$3.4M-73%
Q2 2026$5.5M+10%
Q1 2026$1.9M—
Q3 2025$12.5M—
Q2 2025$5.0M—

From Lenz Therapeutics' 10-Q filed Nov 3, 2026 (on EDGAR).

Questions

How does Lenz Therapeutics make money?

Lenz Therapeutics (LENZ) made $3.4M of revenue in the third quarter 2026 (Q3 2026), -73% from a year earlier. Product sales, net brought in $2.6M (77%); License revenue brought in $785K (23%).

What is Lenz Therapeutics' biggest business?

Product sales, net: $2.6M in the third quarter 2026, 77% of revenue.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.